FDA Inspection 1271161 — Elizabeth Arden, Inc.

Elizabeth Arden, Inc. — FEI 3013779173

The FDA completed an inspection of Elizabeth Arden, Inc. on May 30, 2025 in Salem, VA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
May 30, 2025
Fiscal Year
2025
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Salem, VA (United States)

Citations

IDCFRDescription
354721 CFR 211.46(b)Equipment for Environmental Control